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OUTCOME OF ENDOSCOPIC THERAPEUTIC INTERVENTIONS: ARE 
THEY DIFFERENT AMONG VARIOUS NON- MALIGNANT 
ESOPHAGEAL DISEASES  
Rustam Khan, Shahab Abid, Saeed Hamid, Zaigham Abbas, Hasnain Shah, Wasim Jafri 
Section of Gastroenterology, Department of Medicine, The Aga Khan University Hospital, Karachi, Pakistan 
Background: This study was carried out to evaluate and compare the outcome of various causes 
of non-malignant lesions of the esophagus after endoscopic therapeutic intervention. Methods: A 
cohort of patients with non-malignant dysphagia presenting at Aga Khan University hospital, a 
tertiary care setting who underwent endoscopic intervention was studied. Response to treatment 
was evaluated by improvement in dysphagia score on a scale of 0-4 and weight gain.  Results: 99 
subjects (53 males) were included. Mean age was 48.6±17.2 years. Dysphagia for solids was 
present in 48%, for liquids in 3% and for both in 49% patients. Significant weight loss (>10% 
body weight) occurred in 35 (35.3%) patients. Achalasia was diagnosed in 49.5%, peptic stricture 
in 30.4%, post sclerotherapy stricture in 12.1%, corrosive injury in 4%, post-operative stricture in 
4%. In comparative analysis of achalasia and inflammatory groups, good response to dysphagia 
was seen in 40/49 (82%) and 22/50 (44%) respectively p < 0.001. Weight gain was 35/49 (72%) 
and 22/50 (44%) p <0.001 respectively. Significantly, more endoscopic sessions were required in 
inflammatory group compare to achalasia; 2.2 and 1.1 respectively; p <0.001 and 16% 
complications rate in inflammatory group comparing to no complications in achalasia. 
Conclusions: Dysphagia and weight loss were common presentations in non-malignant 
esophageal diseases. Therapeutic intervention in inflammatory group was associated with high 
complication than the achalasia group. 
Key words: outcome of non-malignant esophageal diseases, Benign esophageal lesions, 
Achalasia, esophageal strictures. 
INTRODUCTION 
Dysphagia and weight loss are manifestations of 
various esophageal diseases. This includes both 
malignant and non-malignant conditions. Among the 
malignant lesions, carcinoma of esophagus is the 
commonest cause1 and in non-malignant lesions, 
peptic stricture and achalasia are relatively common 
causes.2 Therapeutic approaches and outcome in 
terms of overall survival are different in non-
malignant conditions from the malignant. Moreover, 
there is a gross variability in response to endoscopic 
therapeutic intervention in patients even within 
various non-malignant esophageal lesions. This 
variability in the response among various non-
malignant esophageal diseases was never compared. 
This study was aimed to evaluate and compare the 
outcome of the patients with different causes of non-
malignant esophageal lesions presented with 
dysphagia and weight loss after therapeutic 
endoscopic interventions.  
MATERIAL AND METHODS 
During the study period from January 1999 till 
December 2001, patients with dysphagia and weight 
loss were evaluated. Those who fulfil the criteria 
were enrolled for intervention and followed up for 
long-term outcome after therapeutic interventions.  
Patients aged more than 18 years with symptoms 
of dysphagia and weight loss who had benign 
esophageal lesion on investigations were included. 
While patients with malignant esophageal or gastric 
lesions, central neurological causes of dysphagia, 
systemic illnesses accounting for weight loss e.g. 
diabetes mellitus, collagen vascular disease etc, 
extrinsic structural lesions of the neck and chest 
causing compression, pregnancy and esophageal 
varices were excluded.Similarly patients who were 
not fit for endoscopic intervention were also 
excluded. 
 Weight loss was considered significant if the loss 
was more than 10% of body weight in six months 
prior to presentation. Clinical history and physical 
examination were done to exclude non-esophageal 
causes of weight loss. These patients then underwent 
barium swallow followed by endoscopic procedures. 
Diagnosis of the non-malignant lesions were based 
on histology if required, relevant history of corrosive 
ingestion, sclerotherapy, acid peptic disease etc. 
Achalasia was diagnosed on barium esophagogram 
and endoscopic findings. Endoscopic procedure was 
done in conscious sedation after taking informed 
consent. Sedation used was midazolam 2-5 mg until 
the patient was relaxed and fully sedated. Procedures 
were done under fluoroscopic guidance. For achalasia 
graded dilatation with pneumatic balloon 30 mm to 
35 mm was done for 60-90 seconds. For 
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inflammatory strictures Savary-gilliard dilator 5-17 
mm were used for dilatation. Immediate 
complications if any were noted. 
Patients were followed in clinics for one year. 
Response to treatment was evaluated on 1st post 
procedure visit after one week by physician not 
involved in the procedure. Improvement was 
evaluated by subjective improvement in dysphagia 
Score 0 - 4; where score 4 meant best response with 
no dysphagia. Score 3 mild dysphagia for solids, 
Sscore 2 where patient could only swallow semi solid 
things, Score 1 liquid only and score 0, complete 
dysphagia. Patient’s weight was also recorded on 
follow up visits and best weight in six months after 
procedure was taken. Patients with peptic stricture 
were continued on proton pump inhibitors after 
procedure. 
RESULTS 
Ninety-nine patients (53 males) were eligible for 
analysis (Table 1 & 2). Mean age was 48.6±17.2 
years. Dysphagia for solids was present in 48%, for 
liquids in 3% and for both in 49% patients. All 
patients had history of weight loss but 35 (35.5%) of 
them had significant loss of weight. Total numbers of 
161 dilatation session were done in 99 patients. With 
mean of 1.5 sessions per patient this includes; 
pneumatic balloon dilatation 35% and Savory 
Gilliard dilators 65%.  In comparative analysis of 
achalasia and inflammatory groups (table 3), good 
response to dysphagia (score 4) was seen in 40/49 
(82%) and 22/ 50 (44%) respectively p < 0.001. 
Weight gain was 35/49 (71%) and 22/50 (44%) p < 
0.001 respectively.   
These patients were followed-up for mean of 
322 days ± 88 days. Number of endoscopic sessions 
during the follow-up period were more in 
inflammatory group compared to achalasia group; 2.2 
(range 1 – 8) vs. 1.1(range 1 – 2). P < 0.001. In 
inflammatory group, 8/50 (16%) patients had 
complications comparing to no complications in 
achalasia. These complications were perforation in 
6(12%), bleeding requiring transfusion in one patient 
and local abscess in another patient. Among the 
patients who had perforation, 3/6 had underlying post 
corrosive stricture and in another three patients, 
underlying pathology was peptic stricture. Four 
patients with perforation were managed 
conservatively and improved.  
One 50 years old  female patient with peptic 
stricture had perforation underwent  surgery for 
repair and another patient with post corrosive 
stricture died following perforation due to 
mediastinitis and sepsis.  
 
Table-1: Patient characteristics (n = 99) 
 Patient’s characteristic Achalasia 
(n 49) 
Inflammatory
(n 50) 
Male 28 (57%) 26 (52%) 
Female 21 (43%) 24 (48%) 
 Mean age 45.5 ± 15.3 51.7 ± 18 
Dysphagia for solids 26 (53%) 22 (44%) 
Dysphagia for liquids 1 (2%) 2 (4%) 
Both solids and liquids 22 (45%) 26 (52%) 
Significant weight loss  
(>10 % body weight in 6 
months) 
 
16(32. %) 
 
19(38%) 
 
49 (100%) 
 
- 
Therapeutic interventions 
1. Pneumatic balloon 
dilatation sessions 
 
2. Savary Gilliard 
dilatation - 50 (100%) 
Total no of procedures 163 Mean 1.5 
DISCUSSION 
Achalasia, inflammatory strictures and esophageal 
webs and schatzki’s rings are all different but benign 
entities. They all present with dysphagia and weight 
loss and treated with therapeutic endoscopic 
interventions.1,2 Successful outcome after therapeutic 
intervention may be measured by pressure changes in 
the esophagus, height and width of barium column 
measured on radiograph and rate of esophageal 
emptying in these patients.  However the mainstay of 
success is improvement in dysphagia and weight 
gain,3-5 same parameters are used in this study. 
Clinical  parameters in this series has shown an 
overall good response to endoscopic treatment in 
64% patients in terms of dysphagia and 57% patients 
had significant  weight gain after therapeutic 
interventions. 
Several options are available for treatment 
of achalasia. Pneumatic balloon dilatation is effective 
and economical method with low complications1 
rates. Graded dilatation was proved safer if procedure 
begins with 30 mm balloon, good to excellent 
response was seen up to 77% patients, moderate 
response in 12% patients in long-term follow-up for 
3-12 years.4 In another study good to excellent 
response to pneumatic dilatation and Heller’s 
myotomy was found comparable i.e. 88% vs. 89 % if 
skilled operators were available.11 In the present 
series of 49 achalasia patients, good response to 
dysphagia was seen in 40(82%) patients and 35(72%) 
patients gained significant weight after dilatation 
procedures. Only one patient required Heller’s 
myotomy because of poor response to pneumatic 
balloon dilatation. In literature incidence of 
esophageal rupture with pneumatic balloon dilatation 
is reported between 0-12 percent and none of the 
patient in this series had this complication.10, 11
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Table-2: Pathological Diagnosis and complications 
Pathology n (%) Perforation Bleeding ٭ Local abscess 
Achalasia 49 (49.5%) - - - 
Peptic stricture 30 (30.45%) 3   
Post sclerotherapy stricture 12 (12.1%) - 1 ٭ - 
Post surgical stricture 4 (4%) - - 1 
Post corrosive ingestion 4 (4%) 3 - - 
٭  Significant bleeding requiring transfusion. 
Table-3: Response and complications in Achalasia and inflammatory groups. 
 
Characteristics 
Achalasia group (n = 49) 
(n).          (%)       95 % C. I 
Inflammatory group n = 50 
(n)          (%)          95 % C.I 
 
P. Value 
Good response. 40 (82) 70-92 22 (44) 27 – 60 
Mild to moderate response. 8 (16) 6 - 26 18 (36) 19 – 51 
Poor response. 1 (2) 0 - 6 10 (20) 7 – 34 
 
< 0.001 
Significant weight gain. 35 (72) 75 - 95 22 (44) 27 – 60 < 0.001 
Average no. of sessions 1.1±0.3* - 0.59-1.57° 2.2±1.7* - 0.59-1.57° < 0.001 
Complications. 0 -- -- 8 (16) --  
n = number; % = percentage; C.I = confidence interval;* = mean with standard deviation;  
° = 95 % C.I of difference of means. 
In an average of 1.1 ± 0.3 sessions were 
required for achalasia patients in the present series 
which is comparable to other published series.1-6  
Benign esophageal stricture is a serious 
complication of gastroesophageal reflux disease 12, 13. 
Response to treatment depends upon the size and 
nature of the stricture and patient selection. These 
patients require 1-9 dilatation sessions in a year and 
these sessions can be reduced by concomitant use of 
omeprazol 14, 15. If these patients do not respond to 
dilatation procedures then surgical option are 
considered. 14, 15. Fluoroscopic guided balloon 
dilatation is accepted standard treatment of 
esophageal stricture dilatation. mortality and 
morbidity was less in dilatation with bougies than 
surgery 16, 17. Incidence of esophageal rupture has 
been reported between 12-32 % by dilatation with 
balloon or bougies 18,19,20.In a study 153 patients who 
underwent 1043 dilatation procedure without 
fluoroscopy with Savary Gilliard, bougies and 
endoscopically oriented balloon. Good response was 
seen in 65.5% patients, perforation rate was 2.8% and 
mortality was 0.7 %24. In our series of 50 patients 
with inflammatory strictures who underwent 
dilatation procedure under fluoroscopic guidance 
with Savary Gilliard dilators (5-17 mm), good 
response was seen in 22 (44%) patients. An average 
of 2.2± 1.7 session range from 1-8 were required to 
achieve the response during the follow-up period. In 
the inflammatory group six (12%) patients had 
perforations following endoscopic dilatation. Four of 
them improved on conservative management and one 
patient with peptic stricture required surgery for 
repair of perforation. Another patient with post 
corrosive stricture died following perforation due to 
mediastinitis and sepsis. Among the patients who had 
complications, 3/6 patients had underlying post 
corrosive stricture and in other three patients, peptic 
stricture was the underlying etiology. 
Comparison of achalasia and inflammatory 
stricture in term of response to endoscopic dilatations 
and complications revealed that although both groups 
were similar in manifestation and are non-malignant 
conditions but response to treatment was significantly 
better in achalasia than in inflammatory strictures 
because of apparent difference in the underlying 
diseases. Moreover the number of therapeutic 
endoscopic session during the follow-up period were 
significantly more in inflammatory sub-group 
compared to achalasia group; 2.2 and 1.1 respectively 
p<0.001. 
In conclusion, dysphagia and weight loss 
were common symptoms in non-malignant 
esophageal lesions. Majority of patients showed 
significant improvement following endoscopic 
intervention. Response to endoscopic intervention, 
number of therapeutic endoscopic sessions and 
frequency of complication in achalasia patients were 
significantly better than inflammatory stricture.  
REFERENCES 
1. Katz PO, Gilbert J, Castell DO. Pneumatic dilatation is 
effective long- term treatment for achalasia. Dig Dis Sci 1998; 
43(9):1973-77 
J Ayub Med Coll Abbottabad 2005;17(4) 
                                                                                                                            
2. Yeming W, Somme S, Chenren S, Huiming J, Ming Z. 
Balloon catheter dilatation in children with congenital and 
acquired esophageal anomalies. J Paeds Surg 2000;37(3)398-
402 
3. Eckardt VF, Aignherr C, Bernhard G. Predictors of outcomes 
in patients with achalasia treated by pneumatic dilatation. 
Gastroenterology 1992;103:1732-8. 
4. Vantrappen G. Hellemans J, Deloof W, Valembois P, 
Vandenbroucke J. Treatment of achalasia with pneumatic 
dilations. Gut 1971;12:268-75. 
5. Kim HC, Cameron AJ, Hsu JJ, Talley NJ, Trastek VF, 
Pairolero PC et al. Achalasia: Prospective evaluation of 
relationship between lower esophageal sphincter pressure, 
esophageal transit and esophageal diameter and symptoms in 
response to pneumatic dilatation. Mayo Clin Proc 
1993;68:1067-73. 
6. Cocia G, Bortolotti M, Michetti P, Dodero M. Prospective 
clinical and manometric study comparing pneumatic dilation 
and sublingual nifedipine in the treatment of oesophageal 
achalasia. Gut 1991;32:604-6. 
7. Spiess AE, Kahrilas PJ. Treating Achalasia from whalebone to 
laparoscope. JAMA 1998;280(7)638-42. 
8. Sabharwal T, Cowling M, Dussek J, Owen W, Adam A. 
Balloon Dilation for Achalasia of the Cardia: Experience in 76 
patients Radiology 2002; 719-24. 
9. Parkman HP, Reynolds JC, Ouyang A, Rosato EF, Eisenberg 
JM, Cohen S. Pneumatic dilatation or esophagomyotomy 
treatment for idiopathic achalasia: Clinical outcomes and cost 
analysis. Dig Sci 1993;38:75-85. 
10. Csendes A, Braghetto I, Henriquez A, Cortes C. Late results of 
a prospective randomized study comparing forceful dilatation 
and oesophagomyotomy in patients with achalasia. Gut 
1989;30(3):299-304. 
11. Abid S, Champion G, Richter JE, McElvein R, Slaughter RL, 
Koehler RE. Treatment of achalasia: the best of both worlds. 
Am J Gastroenterol 1994;89(7): 979-85. 
12. Hussain SZ, Thomas R, Tolia V. A review of achalasia in 33 
Children. Dig Dis Sci 2002;47(11)2538-43. 
13. Reynold JC, Parkman HP. Achalasia. Gastroenterol clin North 
Am 1989;18:223-55. 
14. London RL, Trotman BW, Di Marino AJ. Dilatation of severe 
esophageal strictures by an inflatable balloon catheter. 
Gastroenterology 1981;80:173-5. 
15. Johnson A, Jensen LI, Mauritzen K. Balloon-dilation of 
esophageal strictures in children. Pediatr Radiol 1986;16:388-
91. 
16. Braghetto I, Csendes A, Burdiles P, Korn O, Compan A, 
Guerra JF. Barrett’s Esophagus Complicated with Stricture: 
Correlation between Classification and the results of the 
Different therapeutic Options. World J Surg 2002;26:1228-33. 
17. Csendes A, Braghetto I. Peptic ulcer of the esophagus 
secondary to reflux esophagitis. Gullet 1991;1:177-84. 
18. Zaninotto G, DeMeester T, Bremner C. Esophageal function in 
patients with reflux induced strictures and its relevance to 
surgical treatment. Ann Thorac Surg 1989;47:362-70. 
19. Barkum AN, Mayrand S. The treatment of peptic esophageal 
stricture. Can J Gastroenterol 1997;11(Suppl B): 94-7 
20. Bischof G, Feil W, Riegler M. Peptic esophageal stricture: is 
surgery still necessary? Wien Klin Wochenschr 1996;108:267-
71 
21. Agnew SR, Pandya SP, Reynolds RP. Predictors for frequent 
esophageal dilatations of benign peptic strictures. Dig Dis Sci 
1996; 41: 931-6 
22. Song HY, Han YM, Kim HN, Kim CS, Choi KC. Corrosive 
esophageal stricture safety and effectiveness of balloon 
dilation. Radiology 1992;184:373-8. 
23. Kim IO, Yeon KM, Kim WS, Park KW, Kim JH, Han MC. 
Perforation complicating balloon dilation of esophageal 
strictures in infants and children. Radiology 1993;189:741-4. 
24. Pereira-Lima JC, Ramires RP, Zamin I, Cassal AP, Marroni 
CA, Mattos AA. Endoscopic dilation of Benign Esophageal 
Strictures: Report on 1043 Procedures. Am J Gastroenterol 
1999;94(6):1497-01. 
_____________________________________________________________________________________________ 
Address for Correspondence:  
Dr. Shahab Abid, Department of Medicine, Aga Khan University, Stadium Road P.O.Box 3500, Karachi 74800, 
Pakistan. Tel. # 9221-4930051, Fax # 9221-4934694 
Email: shahab.abid@aku.edu
